MiR-203 improves cardiac dysfunction by targeting PARP1-NAD+ axis in aging murine

Aging Cell. 2024 Mar;23(3):e14063. doi: 10.1111/acel.14063. Epub 2023 Dec 14.

Abstract

Heart aging is a prevalent cause of cardiovascular diseases among the elderly. NAD+ depletion is a hallmark feature of aging heart, however, the molecular mechanisms that affect NAD+ depletion remain unclear. In this study, we identified microRNA-203 (miR-203) as a senescence-associated microRNA that regulates NAD+ homeostasis. We found that the blood miR-203 level negatively correlated with human age and its expression significantly decreased in the hearts of aged mice and senescent cardiomyocytes. Transgenic mice with overexpressed miR-203 (TgN (miR-203)) showed resistance to aging-induced cardiac diastolic dysfunction, cardiac remodeling, and myocardial senescence. At the cellular level, overexpression of miR-203 significantly prevented D-gal-induced cardiomyocyte senescence and mitochondrial damage, while miR-203 knockdown aggravated these effects. Mechanistically, miR-203 inhibited PARP1 expression by targeting its 3'UTR, which helped to reduce NAD+ depletion and improve mitochondrial function and cell senescence. Overall, our study first identified miR-203 as a genetic tool for anti-heart aging by restoring NAD+ function in cardiomyocytes.

Keywords: NAD+; PARP1; heart aging; miR-203; mitochondrial function.

MeSH terms

  • Aged
  • Aging / genetics
  • Aging / metabolism
  • Animals
  • Cellular Senescence / genetics
  • Heart Diseases*
  • Humans
  • Mice
  • Mice, Transgenic
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Myocytes, Cardiac / metabolism
  • NAD / metabolism
  • Poly (ADP-Ribose) Polymerase-1 / genetics

Substances

  • NAD
  • MicroRNAs
  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1
  • MIRN203 microRNA, human
  • MIRN203 microRNA, mouse